BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 10024977)

  • 21. Ebola virus ecology: a continuing mystery.
    Feldmann H; Wahl-Jensen V; Jones SM; Ströher U
    Trends Microbiol; 2004 Oct; 12(10):433-7. PubMed ID: 15381189
    [No Abstract]   [Full Text] [Related]  

  • 22. Defense against filoviruses used as biological weapons.
    Bray M
    Antiviral Res; 2003 Jan; 57(1-2):53-60. PubMed ID: 12615303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Filoviridae: a taxonomic home for Marburg and Ebola viruses?
    Kiley MP; Bowen ET; Eddy GA; Isaäcson M; Johnson KM; McCormick JB; Murphy FA; Pattyn SR; Peters D; Prozesky OW; Regnery RL; Simpson DI; Slenczka W; Sureau P; van der Groen G; Webb PA; Wulff H
    Intervirology; 1982; 18(1-2):24-32. PubMed ID: 7118520
    [No Abstract]   [Full Text] [Related]  

  • 24. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H
    Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
    J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging diseases. On the trail of Ebola and Marburg viruses.
    Balter M
    Science; 2000 Nov; 290(5493):923-5. PubMed ID: 11184732
    [No Abstract]   [Full Text] [Related]  

  • 27. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
    Nyakarahuka L; Schafer IJ; Balinandi S; Mulei S; Tumusiime A; Kyondo J; Knust B; Lutwama J; Rollin P; Nichol S; Shoemaker T
    BMC Infect Dis; 2020 Jul; 20(1):461. PubMed ID: 32611400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marburg hemorrhagic fever--the forgotten cousin strikes.
    Feldmann H
    N Engl J Med; 2006 Aug; 355(9):866-9. PubMed ID: 16943398
    [No Abstract]   [Full Text] [Related]  

  • 29. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
    Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
    J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
    Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
    Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.
    Chan SY; Speck RF; Ma MC; Goldsmith MA
    J Virol; 2000 May; 74(10):4933-7. PubMed ID: 10775638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marburg and Ebola viruses.
    Feldmann H; Klenk HD
    Adv Virus Res; 1996; 47():1-52. PubMed ID: 8895830
    [No Abstract]   [Full Text] [Related]  

  • 35. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.
    Misasi J; Chandran K; Yang JY; Considine B; Filone CM; Côté M; Sullivan N; Fabozzi G; Hensley L; Cunningham J
    J Virol; 2012 Mar; 86(6):3284-92. PubMed ID: 22238307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ebola and Marburg fever--outbreaks of viral haemorrhagic fever].
    Chlíbek R; Smetana J; Vacková M
    Klin Mikrobiol Infekc Lek; 2006 Dec; 12(6):217-23. PubMed ID: 17230375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of filoviral haemorrhagic fevers.
    Mahanty S; Bray M
    Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Filoviruses: recent advances and future challenges.
    Bray M; Pilch R
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):917-21. PubMed ID: 17181407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.
    Saijo M; Niikura M; Ikegami T; Kurane I; Kurata T; Morikawa S
    Clin Vaccine Immunol; 2006 Apr; 13(4):444-51. PubMed ID: 16603611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.